Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medical application of selenium phosphate compound

A compound and selenium salt technology, applied in the field of medicine, can solve problems such as not meeting the property requirements of pharmaceutical products

Active Publication Date: 2014-07-30
SHENZHEN F&S BIO TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are still shortcomings in the efficacy dosage and safe dosage of common selenium agents, which cannot meet the attribute requirements of pharmaceutical products, so it is of great significance to develop selenium agents with anti-cancer and anti-cancer effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical application of selenium phosphate compound
  • Medical application of selenium phosphate compound
  • Medical application of selenium phosphate compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Example 1 Preparation of Selenium Phosphate Complex

[0067] Weigh a certain amount of selenium dioxide and potassium tripolyphosphate respectively, wherein the molar ratio of selenium dioxide and potassium tripolyphosphate is 1.8:1. Dissolve the weighed selenium dioxide in water to prepare 0.2g / ml selenous acid, and pour it into the reactor, then slowly add potassium tripolyphosphate into the selenous acid solution, and adjust the temperature to 250~300°C , Stir, after dehydration, deacidification, generate potassium selenium phosphate complex. The complex obtained by the reaction is dissolved in an appropriate amount of water, neutralized with phosphoric acid to a pH of 6.0-6.5, and then heated and dehydrated to obtain a potassium selenium phosphate complex that can be applied to humans or mammals.

[0068] Weigh a certain amount of selenium dioxide and sodium tripolyphosphate respectively, wherein the molar ratio of selenium dioxide and sodium tripolyphosphate is...

Embodiment 2

[0074] Example 2 Characterization of Selenium Phosphate Complexes

[0075] Adopt nuclear magnetic resonance to measure the nuclear magnetic resonance spectrum of the phosphate selenium salt complex that obtains in the above-mentioned embodiment, with phosphoric acid 31 PNMR to determine the delta value of the relative phosphorus signal, i.e. set the phosphorous 31 PNMRδ=0ppm where the potassium selenophosphate complex 31 PNMR spectrum such as figure 1 shown. Metal ions have little effect on the phosphorus signal, and the 31 The PNMR spectra are similar, and there are signal peaks of phosphorus at δ=3.0~2.2ppm and δ=-5.6~-6.8ppm.

Embodiment 3

[0076] Example 3 Study on Acute Toxicity of Potassium Selenium Phosphate Compound

[0077] Sixty SPF-grade Kunming mice were randomly divided into 6 groups according to body weight, with 10 mice in each group, half male and half male. The experiment consisted of blank control group (distilled water), potassium selenium phosphate oral liquid 24.75, 19.80, 15.84, 12.67, 10.14 mg / kg five groups, a total of 6 groups, administered by intragastric administration. Immediately after the administration, observe the reaction of the animals for 12 hours, and then observe once a day for 14 consecutive days.

[0078] Experimental results: Table 1 lists the body weight changes of the mice in the experiment. In the blank control group, no obvious abnormal reaction was found within 14 days, and the body weight increased well. After administration of potassium selenium phosphate oral liquid at a concentration of 24.75mg / kg, the mice immediately experienced decreased activity, dyspnea, limb ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a use of a selenium phosphate complex M3(SeP3O10)n XH2O in the preparation of medicines for treating and / or preventing hyperproliferative disorders in humans or mammals, wherein X=0~4, n is 1 or 2, when n=1, M is alkali metal or ammonium ion; when n=2, M is alkaline earth metal. In addition, the present invention provides the use of the above-mentioned selenium phosphate complex M3(SeP3O10)n·XH2O in the preparation of medicines for preventing and / or treating human diseases related to selenium deficiency, such as Keshan disease or cataract. The selenium phosphate compound provided by the invention can be used to treat and / or prevent hyperproliferative disorders in humans or mammals, including various cancers and tumors, without adverse reactions and side effects, improves the quality of life of patients, and has excellent compliance.

Description

technical field [0001] The invention belongs to the field of medicine, in particular to the medical application of selenium phosphate compound. Background technique [0002] Since the discovery of selenium as an essential microelement for humans and animals in 1957, scientists have discovered 14 selenoenzymes and selenoproteins, including 4 glutathione peroxidases, 3 thyroxine deiodinases, and 3 selenoproteins. Thioredoxin reductase, selenophosphate synthase 2, selenoprotein w, selenoprotein p, and 15KDa selenoprotein, all of which, except for selenoprotein p, contain only one selenocysteine ​​residue in sequence base (this is the active center site of the enzyme). Selenium enzymes and selenoproteins play an important role in regulating the reduction state of cells and removing excess reactive oxygen species produced in the body. [0003] At present, more and more evidence shows that selenium plays an important role in preventing and fighting cancer. Based on studies in m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K33/42A61P35/00A61P3/02A61P27/12A61P9/00
Inventor 李福初彭锋
Owner SHENZHEN F&S BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com